No Data
No Data
EZZ Life Science Sees AU$19 Million in Cash by End of Q4
EZZ Life Science Holdings (ASX:EZZ) expects to have about AU$19 million in cash by the end of the fourth quarter of its financial year 2024, according to a Thursday Australian bourse filing. The discl
EZZ Life Science Targets US Expansion
EZZ Life Science Holdings (ASX:EZZ) has set its sights on the lucrative US market after securing regulatory clearance from the United States Food and Drug Administration (FDA) for nine of its products
EZZ Life Science Eyes US Market Expansion After Receiving FDA Approval for Nine Products
EZZ Life Science Holdings (ASX: EZZ) has received approval for nine of its products in the food category from the US Food and Drug Administration (FDA).
Stocks of the Hour: Telix Pharmaceuticals, AVITA Medical, EZZ Life Science
To register for today's webinar click here.Telix Pharmaceuticals (ASX:TLX) announces additional positive data from the ProstACT SELECT trial of TLX591. TLX591 is an investigational anti-PSMA1 radio-an
Is EZZ Life Science Holdings Limited's (ASX:EZZ) Recent Stock Performance Tethered To Its Strong Fundamentals?
EZZ Life's Receipts From Customers Up 111% in Fiscal Q3
EZZ Life Science Holdings (ASX:EZZ) recorded receipts from customers totaling AU$23.6 million in the third quarter of fiscal 2024, a 111% increase on the year-ago period, according to a Wednesday fili
No Data